Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 279-919-6 | CAS number: 82205-20-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- December 2015 - April 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline for the testing of chemicals No. 490 (adopted July 2015).
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- [2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2-hydroxypropyl)dimethylammonium chloride
- EC Number:
- 259-033-6
- EC Name:
- [2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2-hydroxypropyl)dimethylammonium chloride
- Cas Number:
- 54229-13-9
- Molecular formula:
- C21H29ClN5O3.Cl
- IUPAC Name:
- [2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2- hydroxypropyl)dimethylammonium chloride
- Test material form:
- solid: particulate/powder
- Details on test material:
- see below
Constituent 1
Method
- Target gene:
- The mutation assay method used in this study is based on the identification of
L5178Y colonies which have become resistant to a toxic thymidine analogue
trifluorothymidine (TFT). This analogue can be metabolised by the enzyme
thymidine kinase (TK) into nucleosides, which are used in nucleic acid
synthesis resulting in the death of TK-competent cells.
TK-deficient cells, which are presumed to arise through mutations in the TK
gene, cannot metabolise trifluorothymidine and thus survive and grow in its
presence.
In the L5178Y mouse lymphoma cells, the gene which codes for the TK
enzyme is located on chromosome 11. Cells which are heterozygous at the TK
locus (TK+/-) may undergo a single step forward mutation to the TK-/-
genotype in which little or no TK activity remains.
The mouse lymphoma assay often produces a bimodal size distribution of
TFT resistant colonies designated as small or large. It has been evaluated
that point mutations and deletions within the active allele (intragenic event)
produce large colonies. Small colonies result in part from lesions that affect
not only the active TK allele but also a flanking gene whose expression
modulates the growth rate of cells.
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI 1640 medium supplemented with 10% Foetal Calf Serum (RPMI
complete)
- Properly maintained: yes; permanent stock of mouse lymphoma L5178Y cells are stored in liquid
nitrogen and subcoltures are prepared from the frozen stocks for experimental use.
- Periodically checked for Mycoplasma contamination: yes
- The generation time, plating efficiency and mutation rates (spontaneous and induced) have been
checked in this laboratory.
- Periodically "cleansed" against high spontaneous background: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 tissue fraction: Species: Rat Strain: Sprague Dawley Tissue: Liver Inducing Agents: Phenobarbital – 5,6-Benzoflavone Producer: MOLTOX, Molecular Toxicology, Inc. Batch Number 3512
- Test concentrations with justification for top dose:
- A preliminary cytotoxicity assay was performed at the following dose levels: 1000, 500, 250, 125, 62.5, 31.3, 15.6, 7.81 and 3.91 µg/mL.
Based on the results obtained in the preliminary cytotoxicity assay, two independent assays
for mutation at the TK locus were performed using the following dose levels:
Main Assay I (-S9; treatment time 3 hours): 60.2, 43.0, 30.7, 22.0, 15.7 and 11.2 μg/mL
Main Assay I (+S9; treatment time 3 hours): 100, 50.0, 25.0, 12.5, 6.25 and 3.13 μg/mL
Main Assay II (-S9; treatment time 24 hours): 35.0, 25.0, 17.9, 12.8, 9.11 and 6.51 μg/mL - Vehicle / solvent:
- Test item solutions were prepared using dimethylsulfoxide (DMSO)
Controls
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- methylmethanesulfonate
- Details on test system and experimental conditions:
- A preliminary cytotoxicity test was performed in order to select appropriate dose levels for the mutation assays. In this
test a wide range of dose levels of the test item was used and the survival of the cells was subsequently determined.
Treatments were performed in the absence and presence of S9 metabolic activation for 3 hours and for 24 hours only in
the absence of S9 metabolic activation. A single culture was used at each test point.
The mutation assays were performed including vehicle and positive controls, in the absence and presence of S9
metabolising system.
Duplicate cultures were prepared at each test point, with the exception of the positive controls which were prepared in a
single culture.
In the first experiment, the cells were exposed to the test item for a short treatment time (3 hours). Since negative results
were obtained without metabolic activation, the second experiment in the absence of S9 metabolism was performed, using a longer treatment
time (24 hours).
After washing in Phosphate Buffered Saline (PBS), cells were resuspended in fresh complete medium (10%) and
incubated to allow expression of the mutant phenotype. At the end of the expression period cells were plated for the evaluation of
5-trifluorothymidine resistance and for viability. - Evaluation criteria:
- For a test item to be considered mutagenic in this assay, it is required that:
1. The induced mutant frequency (IMF) is higher than the global evaluation factor (GEF)
suggested for the microwell method (126x10^-6) at one or more doses.
2. There is a significant dose-relationship as indicated by the linear trend analysis.
Results which only partially satisfy the above criteria will be dealt with on a case-by-case
basis. Similarly, positive responses seen only at high levels of cytotoxicity will require careful
interpretation when assessing their biological significance. Any increase in mutant frequency
should lie outside the historical control range to have biological relevance. - Statistics:
- Statistical analysis was performed according to UKEMS guidelines (RobinsonW.D., 1990).
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Survival after treatment:
In the first experiment, in the absence of S9 metabolic activation, no cell survived after treatment at the highest dose level, moderate toxicity reducing relative total growth (RTG) to 14% of the concurrent negative control was noted at 43.0 µg/mL, slight to mild toxicity was observed between 15.7 and 30.7 µg/mL, while no relevant toxicity was noted at the lowest concentration tested. In the presence of S9 metabolism, treatment with the test item at 100 µg/mL yielded moderate toxicity reducing RTG to 24% of the concurrent negative control value, slight toxicity was noted at the next lower concentration, while no relevant toxicity was observed over the remaining concentrations tested.
In the second experiment, in the absence of S9 metabolic activation using a long treatment time, the highest dose level selected (35 µg/mL)
yielded marked toxicity reducing RTG to 8% of the concurrent negative control value. The next two lower dose levels of 25.0 and 17.9 µg/mL yielded moderate toxicity reducing RTG to 15 and 26%, respectively. Dose-related toxicity was seen over the remaining dose levels tested.
Mutation results:
InMain Assay I, statistically significant increases in mutant frequency were observed at the lowest and at two intermediate concentrations, in the absence of S9 metabolism, and at the highest dose level in its presence. A linear trend was indicated, both in the absence and presence of S9 metabolism.
However, the observed increases were lower than the Global Evaluation Factor both in the absence and presence of S9 metabolism, thus they were
considered of no biological relevance. In Main Assay II, no increases in mutant frequency were observed at any concentration tested.
Any other information on results incl. tables
See Final Report
Applicant's summary and conclusion
- Conclusions:
- It is concluded that Basic Red 18:1 Chloride does not induce mutation at the TK locus of L5178Y mouse lymphoma cells in vitro in the absence or presence of S9 metabolic activation, under the reported experimental conditions.
- Executive summary:
The test item Basic Red 18:1 Chloride was examined for mutagenic activity by assaying for the induction of 5 trifluorothymidine resistant mutants in mouse lymphoma L5178Y cells after in vitro treatment, in the absence and presence of S9 metabolic activation, using a fluctuation method. A preliminary solubility trial indicated that the maximum practicable concentration of the test item in the final treatment medium was 1000 µg/mL using dimethylsulfoxide (DMSO) as solvent. On the basis of this result, a cytotoxicity assay was performed. Both in the absence and presence of S9 metabolic activation, the test item was assayed at a maximum dose level of 1000 µg/mL and at a wide range of lower dose levels: 500, 250, 125, 62.5, 31.3, 15.6, 7.81 and 3.91 µg/mL. In the absence of S9 metabolic activation, using the 3 hour treatment time, no cells were recovered after treatment starting from 62.5 µg/mL. At the next two lower dose levels of 31.3 and 15.6 µg/mL, slight toxicity was observed, reducing relative survival (RS) to 57 and 67% of the concurrent negative control value, respectively. No relevant toxicity was noted over the remaining concentrations tested. Using the 24 hour treatment time, no cells survived to treatment starting from 62.5 µg/mL, moderate toxicity was noted at the next lower concentration (RS=16%), while slight toxicity was observed at 15.6 µg/mL, reducing relative survival to 58%. No relevant toxicity was observed over the remaining dose levels tested. Following treatment in the presence of S9 metabolic activation, using the short treatment time (3 hours), no cells survived to treatment at 1000, 500 and 250 µg/mL. Test item treatment at 125 µg/mL yielded severe toxicity reducing RS to 1%, while no relevant toxicity was observed over the remaining dose levels tested. Based on the results obtained in the preliminary trial, two independent assays for mutation at the TK locus were performed using the dose levels described in the following table:
Main Assay I (-S9; treatment time 3 hours): 60.2, 43.0, 30.7, 22.0, 15.7 and 11.2 μg/mL
Main Assay I (+S9; treatment time 3 hours): 100, 50.0, 25.0, 12.5, 6.25 and 3.13 μg/mL
Main Assay II (-S9; treatment time 24 hours): 35.0, 25.0, 17.9, 12.8, 9.11 and 6.51 μg/mL
Adequate levels of cytotoxicity, covering a range from the maximum to slight or no toxicity, were observed in all treatment series. No relevant increases in mutant frequencies were observed following treatment with the test item, in the absence or presence of S9 metabolism. Negative and positive control treatments were included in each mutation experiment in the absence and presence of S9 metabolism. The mutant frequencies in the solvent control cultures fell within the normal range. Marked increases were obtained with the positive control treatments indicating the correct functioning of the assay system. It is concluded that Basic Red 18:1 Chloride does not induce mutation at the TK locus of L5178Y mouse lymphoma cells in vitro in the absence or presence of S9 metabolic activation, under the reported experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.